Ignite Creation Date:
2024-05-05 @ 4:36 PM
Last Modification Date:
2024-10-26 @ 9:22 AM
Study NCT ID:
NCT00278213
Status:
COMPLETED
Last Update Posted:
2018-05-11
First Post:
2006-01-16
Brief Title:
Combination Chemotherapy Followed By Alemtuzumab in Treating Patients With Chronic Lymphocytic Leukemia or Prolymphocytic Leukemia
Sponsor:
German CLL Study Group
Organization:
German CLL Study Group
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Prolymphocytic Leukemia |
Keywords:
| Name | View |
|---|---|
| prolymphocytic leukemia | View |
| refractory chronic lymphocytic leukemia | View |
| stage I chronic lymphocytic leukemia | View |
| stage II chronic lymphocytic leukemia | View |
| stage III chronic lymphocytic leukemia | View |
| stage IV chronic lymphocytic leukemia | View |
| T-cell large granular lymphocyte leukemia | View |